BASi (BASI) Names Dawn M. Joseph Director Of Business Development

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Bioanalytical Systems, Inc. ("BASi") (NASDAQ:BASI) today announced the appointment of Dawn M. Joseph as Director of Business Development reporting to BASi Vice President of Business Development, Connie Dougherty. Ms. Dougherty said, "Dawn Joseph joins BASi with 11 years of experience in the pharmaceutical services market as a business development manager, with a track record of building sales and implementing winning initiatives for the clients.

Suggested Articles

The inclusion of Kupffer cells in in vitro hepatic cultures provides researchers with advanced tools for disease modeling and drug discovery.

A delay to Moderna's phase 3 COVID-19 study is part of a trend of tensions in the biotech’s relationship with the U.S. government, Reuters reported.

GlaxoSmithKline is continuing its strategy of giving out access to its vaccine platform as it adds Medicago to its growing partners list.